Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Abbott Laboratories (ABT)

Abbott Laboratories Stock Drops 4% Over Decline In Q1 Earnings 4/16/2026 9:53:27 AM

Abbott Updates FY26 Guidance To Reflect Acquisition Of Exact Sciences 4/16/2026 7:57:34 AM

Abbott Laboratories Reports Retreat In Q1 Profit 4/16/2026 7:35:46 AM

Abbott Q1 EPS Declines To $0.61 From $0.76 Last Year 4/16/2026 7:32:33 AM

Abbott Laboratories Q1 26 Earnings Conference Call At 9:00 AM ET 4/16/2026 6:03:15 AM

Abbott Closes Acquisition Of Exact Sciences 3/23/2026 8:52:54 AM

Abbott Expects To Close Exact Sciences Acquisition On March 23, 2026 3/20/2026 9:06:40 AM

Weekly Buzz: BMY Wins FDA Nod; EU Okays JNJ's AKEEGA; IPSEY Withdraws Tazverik, DAWN Acquired 3/13/2026 10:14:13 AM

Abbott: FreeDM2 Trial Data Shows Libre Technology Achieves 0.6% Greater Reduction In HbA1c 3/12/2026 8:37:13 AM

Abbott’s FreeDM2 Trial Shows FreeStyle Libre CGM Outperforms Fingersticks In Glucose Control 3/12/2026 8:17:15 AM

Abbott Declares Quarterly Dividend Of $0.63/share, Payable May 15/ Record April 15 2/20/2026 1:17:20 PM

Abbott Reports Positive 12-month Results From VOLT-AF IDE Study 2/6/2026 8:35:34 AM

Abbott : New Clinical Data Shows Safety And Efficacy Of Minimally Invasive AFib Therapies 2/6/2026 8:10:11 AM

Abbott Stock Slides 7% After Q4 Results And 2026 Outlook Disappoint Investors 1/22/2026 11:00:58 AM

Abbott Projects 2026 Organic Sales Growth In Range Of 6.5% To 7.5% 1/22/2026 8:07:20 AM

Abbott Laboratories Announces Decline In Q4 Bottom Line 1/22/2026 7:48:20 AM

Abbott Q4 EPS Of $1.01; Adj. EPS Of $1.50, Growth Of 12% 1/22/2026 7:36:33 AM

Abbott Laboratories Q4 25 Earnings Conference Call At 9:00 AM ET 1/22/2026 6:03:16 AM

Abbott Wins CE Mark For TactiFlex Duo Ablation Catheter To Treat Afib 1/20/2026 9:39:58 AM

Abbott Receives CE Mark For TactiFlex Duo Ablation Catheter To Treat Abnormal Heart Rhythms 1/20/2026 9:13:07 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap